Ranked #1,003 of 8,699 institutional investors
Darwin Global Management, Ltd.
St. Helier, Y9
$3.65B
US stock portfolio at live prices · today −$26.3M (−0.71%)
Market closed. Prices as of Nov 20, 6:41 AM ET
- Value at quarter end (Q3 2026)
- $3.99B
- Change from Q2 2026
- +$231.1M (+6.15%)
- Positions
- 4 · 1 new, 1 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$247M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesRVMD 46.4%GMAB 25.2%BLTE 12.8%ABVX 8.88%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. | 10,629,822 | $1.69B | 46.4% | Unchanged |
| GMAB Genmab A/S | 17,899,876 | $919M | 25.2% | New |
| BLTE Belite Bio, Inc | 3,097,132 | $468M | 12.8% | Added +1% |
| ABVX ABIVAX Société Anonyme | 4,021,583 | $324M | 8.88% | Added +11% |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| INSM Insmed Incorporated | 6,431,163 | $929M |